DMBT1 as an archetypal link between infection, inflammation, and cancer

Inmunologia

Volumn 26, Issue 4, 2007, Pages 193-209

  Mollenhauer, Jan ^a,b   End, C ^a   Renner, M ^a   Lyer, S ^a,b   Poustka, A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cancer; DMBT1; Infection; Inflammation; Scavenger receptor

Indexed keywords

COMPLEMENT COMPONENT C1Q; GALECTIN 3; IMMUNOGLOBULIN A; LACTOFERRIN; MUCIN 5B; PROTEIN; SCAVENGER RECEPTOR CYSTEINE RICH PROTEIN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ACTINOBACILLUS; ACTINOMYCES; ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; BACTEROIDES FRAGILIS; BILIARY TRACT INFECTION; CELL PROTECTION; CELLULITIS; CHROMOSOME REARRANGEMENT; DENTAL CARIES; DIARRHEA; DISEASE ASSOCIATION; DOWN REGULATION; ENDOCARDITIS; EPITHELIUM; ESCHERICHIA COLI; EVOLUTION; GASTRITIS; GASTROENTERITIS; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOMICS; HAEMOPHILUS INFLUENZAE TYPE A; HELICOBACTER PYLORI; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; INFLUENZA VIRUS A; INNATE IMMUNITY; KLEBSIELLA OXYTOCA; LACTOBACILLUS CASEI; MENINGITIS; MOLECULAR BIOLOGY; MORAXELLA CATARRHALIS; MUCOSAL IMMUNITY; NEISSERIA MENINGITIDIS; NEOPLASM; NONHUMAN; PATHOGENESIS; PEPTOSTREPTOCOCCACEAE; PERIODONTITIS; PHARYNGITIS; PNEUMONIA; PREVOTELLA INTERMEDIA; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATIC FEVER; SALMONELLA ENTERICA; SCARLET FEVER; SEPTICEMIA; STAPHYLOCOCCUS AUREUS; STEM CELL; STOMACH CANCER; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SANGUINIS; STREPTOCOCCUS SOBRINUS; TONSILLITIS; TUMOR SUPPRESSOR GENE; WOUND HEALING; WOUND INFECTION;

EID: 40749158312     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0213-9626(07)70089-6     Document Type: Review

References (141)

1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
2. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-835.
3. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
5. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-1928.
6. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808.
7. Maeda S, Hsu LC, Liu H, Bankston LA, Iimura M, Kagnoff MF, et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1, processing. Science 2005; 307: 734-738.
8. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734.
9. Kim YS, Gum JR, Jr. Diversity of mucin genes, structure, function, and expression. Gastroenterology 1995; 109: 999-1001.
10. Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front Biosci 2001; 6: D1321-1357.
11. Veldch A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002; 295: 1726-1729.
12. Hudson MJ, Stamp GW, Chaudhary KS, Hewitt R, Stubbs AP, Abel PD, et al. Human MUC1 mucin: A potent glandular morphogen. J Pathol 2001; 194: 373-383.
13. Lehrer RI. Primate defensins. Nat Rev Microbiol 2004; 2: 727-738.
14. Markeeva N, Lysovskiy I, Zhuravel E, Soldatkina M, Lyzogubov V, Usenko V, et al. Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix. Exp Oncol 2005; 27: 308-313.
15. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: Control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66: 8542-8549.
16. Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, et al. Functional analysis of the host defense peptide Human Beta Defensin-1: New insight into its potential role in cancer. Mol Immunol 2008; 45: 839-848.
17. Mollenhauer J, Wiemann S, Scheurlen W, Kom B, Hayashi Y, Wilgenbus KK et al. DMBTl, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 1997; 17: 32-39.
18. Mollenhauer J, Holmskov U, Wiemann S, Krebs I, Herbertz S, Madsen J, et al. The genomic structure of the DMBT1 gene: Evidence for a region with susceptibility to genomic instability. Oncogene 1999; 18: 6233-6240.
19. Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, et al. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA 1999; 96: 10794-10799.
20. Mollenhauer J, Herbertz S, Helmke B, Kollender G, Krebs I, Madsen J, et al. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 2001; 61: 8880-8886.
21. Cheng H, Bjerknes M, Chen H. CRP-ductin: A gene expressed in intestinal crypts and in pancreatic and hepatic ducts. Anat Rec 1996; 244: 327-343.
22. Li XJ, Snyder SH. Molecular cloning of Ebnerin, a von Ebner's gland protein associated with taste buds. J Biol Chem 1995; 270: 17674-17679.
23. Matsushita F, Miyawaki A, Mikoshiba K. Vomeroglandin/CRP-Ductin is strongly expressed in the glands associated with the mouse vomeronasal organ: Identification and characterization of mouse vomeroglandin. Biochem Biophys Res Commun 2000; 268: 275-281.
24. De Lisle RC, Ziemer D. Processing of pro-Mudin and divergent trafficking of its products to zymogen granules and the apical plasma membrane of panaeatic acinar cells. Eur J Cell Biol 2000; 79: 892-904.
25. Tandon C, De Lisle RC. Apactin is involved in remodeling of the actin cytoskeleton during regulated exocytosis. Eur J Cell Biol 2004; 83: 79-89.
26. Madsen J, Tornoe I, Nielsen O, Lausen M, Krebs I, Mollenhauer J, et al. CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 PMBTl), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur J Immunol 2003; 33: 2327-2336.
27. Mollenhauer J, Helmke B, Muller H, Kollender G, Lyer S, Diedrichs L, et al. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer 2002; 35: 164-169.
28. Padilla O, Pujana MA, Lopez-de la Iglesia A, Gimferrer I, Arman M, Vila JM, et al. Cloning of S4D-SRCRB, a new soluble member of the group B scavenger receptor cysteine-rich family (SRCR-SF) mapping to human chromosome 7qll.23. Immunogenetics 2002; 54: 621-634.
29. Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 2000; 60: 1704-1710.
30. Mollenhauer J, Muller H, Kollender G, Lyer S, Diedrichs L, Helmke B, et al. The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer. Genes Chromosomes Cancer 2002; 35: 242-255.
31. Sasaki H, Betensky RA, Cairncross JG, Louis DN. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis. Cancer Res 2002; 62: 1790-1796.
32. Pang JC, Dong Z, Zhang R, Liu Y, Zhou LF, Chan BW, et al. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer 2003; 105: 76-81.
33. Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Muller H, et al. Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis. Genes Chromosomes Cancer 2004; 39: 185-194.
34. Wu W, Kemp BL, Proctor ML, Gazdar AF, Minna JD, Hong WK, et al. Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999; 59: 1846-1851.
35. Takeshita H, Sato M, Shiwaku HO, Semba S, Sakurada A, Hoshi M, et al. Expression of the DMBT1 gene is frequently suppressed in human lung cancer. Jpn J Cancer Res 1999; 90: 903-908.
36. Petersen S, Rudolf J, Bockmuhl U, Deutschmann N, Dietel M, Petersen I. Analysis of the DMBT1 gene in carcinomas of the respiratory tract. Int J Cancer 2000; 88: 71-76.
37. Mueller W, Mollenhauer J, Stockhammer F, Poustka A, von Deimling A. Rare mutations of the DMBT1 gene in human astrocytic gliomas. Oncogene 2002; 21: 5956-5959.
38. Mollenhauer J, Deichmann M, Helmke B, Muller H, Kollender G, Holmskov U, et al. Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer. Int J Cancer 2003; 105: 149-157.
39. Mori M, Shiraishi T, Tanaka S, Yamagata M, Mafune K, Tanaka Y, et al. Lack of DMBTl expression in oesophageal, gastric and colon cancers. Br J Cancer 1999; 79: 211-213.
40. Sasaki M, Huang SF, Chen MF, Jan YY, Yen TS, Ishikawa A, et al. Decrease of deleted in malignant brain tumour-1 (DMBT-1) expression is a crucial late event in intrahepatic cholangiocarcinoma. Histopathology 2003; 43: 340-346.
41. Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A, et al. DMBT1 expression is down-regulated in breast cancer. BMC Cancer 2004; 4: 46.
42. Inda MM, Mercapide J, Munoz J, Coullin P, Danglot G, Tunon T, et al. PTEN and DMBT1 homozygous deletion and expression in medullohlastomas and supratentorial primitive neuroectodermal tumors. Oncol Rep 2004; 12: 1341-1347.
43. Imai MA, Moriya T, Imai FL, Shiiba M, Bukawa H, Yokoe H, et al. Downregulation of DMBT1 gene expression in human oral squamous cell carcinoma. Int J Mol Med 2005; 15: 585-589.
44. Kang W, Nielsen O, Fenger C, Leslie G, Holmskov U, Reid KB. Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. Carcinogenesis 2005; 26: 1129-1137.
45. Conde AR, Martins AP, Brito M, Manuel A, Ramos S, Malta-Vacas J, et al. DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types. Int J Oncol 2007; 30: 1441-1446.
46. Sasaki K, Sato K, Akiyama Y, Yanagihara K, Oka M, Yamaguchi K. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 2002; 62: 4894-4898.
47. Bikker FJ, van der Wal JE, Ligtenberg AJ, Mollenhauer J, de Blieck-Hogervorst JM, van der Waal I, et al. Salivary agglutinin/DMBT1SAG expression is up-regulated in the presence of salivary gland tumors. J Dent Res 2004; 83: 567-571.
48. Hustinx SR, Cao D, Maitra A, Sato N, Martin ST, Sudhir D, et al. Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression. Cancer Biol Ther 2004; 3: 1254-1261.
49. Li Z, Szabolcs M, Terwilliger JD, Efstratiadis A. Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. Carcinogenesis 2006; 27: 1054-1067.
50. Mollenhauer J, Helmke B, Muller H, Kollender G, Krebs I, Wiemann S, et al. An integrative model on the role of DMBT1 in epithelial cancer. Cancer Detect Prev 2002; 26: 266-274.
51. Marxfeld H, Grenet O, Bringel J, Staedtler F, Harleman JH. Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profiling. Exp Toxicol Pathol 2006; 58: 151-161.
52. Genter MB, Burman DM, Vijayakumar S, Ebert CL, Aronow BJ. Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa. Physiol Genomics 2002; 12: 3545.
53. Bisgaard HC, Holmskov U, Santoni-Rugiu E, Nagy P, Nielsen O, Ott P, et al. Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1. Am J Pathol 2002; 161: 1187-1198.
54. Schwartz GJ, Barasch J, Al-Awqati Q. Plasticity of functional epithelial polarity. Nature 1985; 318: 368-371.
55. van Adelsberg J, Edwards JC, Takito J, Kiss B, al-Awqati Q. An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells. Cell 1994; 76: 1053-1061.
56. Takito J, Hikita C, Al-Awqati Q. Hensin, a new collecting duct protein involved in the in vitro plasticity of intercalated cell polarity. J Clin Invest 1996; 98: 2324-2331.
57. Takito J, Yan L, Ma J, Hikita C, Vijayakumar S, Warburton D, et al. Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas. Am J Physiol 1999; 277: F277-289.
58. Vijayakumar S, Takito J, Hikita C, Al-Awqati Q. Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation. J Cell Biol 1999; 144: 1057-1067.
59. Hikita C, Takito J, Vijayakumar S, Al-Awqati Q. Only multimeric hensin located in the extracellular matrix can induce apical endocytosis and reverse the polarity of intercalated cells. J Biol Chem 1999; 274: 17671-17676.
60. Hikita C, Vijayakumar S, Takito J, Erdjument-Bromage H, Tempst P, Al-Awqati Q. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. J Cell Biol 2000; 151: 1235-1246.
61. Watanabe S, Tsuruoka S, Vijayakumar S, Fischer G, Zhang Y, Fujimura A, et al. Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin. Am J Physiol Renal Physiol 2005; 288: F4047.
62. Takito J, Al-Awqati Q. Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin. J Cell Biol 2004; 166: 1093-1102.
63. Gassier N, Newrzella D, Bohm C, Lyer S, Li L, Sorgenfrei O, et al. Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine. Gut 2006; 55: 1084-1089.
64. Ward JM, Devor-Henneman DE. Mouse models of human familial cancer syndromes. Toxicol Pathol 2004; 32 Suppl 1: 90-98.
65. Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, et al. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's Disease. Gastroenterology 2007; 133: 1499-1509.
66. Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, et al. Genetic Mapping in Mice Identifies DMBT1 as a Candidate Modifier of Mammary Tumors and Breast Cancer Risk. Am J Pathol 2007; 170: 2030-2041.
67. Holmskov U, Lawson P, Teisner B, Tornoe I, Willis AC, Morgan C, et al. Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem 1997; 272: 13743-13749.
68. Prakobphol A, Xu F, Hoang VM, Larsson T, Bergstrom J, Johansson I, et al. Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340. J Biol Chem 2000; 275: 39860-39866.
69. Ligtenberg TJ, Bikker FJ, Groenink J, Tornoe I, Leth-Larsen R, Veerman EC, et al. Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340. Biochem J 2001; 359: 243-248.
70. Ericson T, Rundegren J. Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur J Biochem 1983; 133: 255-261.
71. Carlen A, Olsson J. Monoclonal antibodies against a high-molecular-weight agglutinin block adherence to experimental pellicles on hydroxyapatite and aggregation of Streptococcus mutans. J Dent Res 1995;74:1040-1047.
72. Carlen A, Olsson J, Borjesson AC. Saliva-mediated binding in vitro and prevalence in vivo of Streptococcus mutans. Arch Oral Biol 1996; 41: 35-39.
73. Carlen A, Bratt P, Stenudd C, Olsson J, Stromberg N. Agglutinin and acidic proline-rich protein receptor patterns may modulate bacterial adherence and colonization on tooth surfaces. J Dent Res 1998; 77: 81-90.
74. Bikker FJ, Ligtenberg AJ, Nazmi K, Veerman EC, van't Hof W, Bolscher JG, et al. Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily. J Biol Chem 2002; 277: 32109-32115.
75. Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, et al. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 2007; 178: 8203-8211.
76. Nagashunmugam T, Malamud D, Davis C, Abrams WR, Friedman HM. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J Infect Dis 1998; 178: 1635-1641.
77. Hartshorn KL, White MR, Mogues T, Ligtenberg T, Crouch E, Holmskov U. Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1066-1076.
78. Tino MJ, Wright JR. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am J Respir Cell Mol Biol 1999; 20: 759-768.
79. Thornton DJ, Davies JR, Kirkham S, Gautrey A, Khan N, Richardson PS, et al. Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin. Glycobiology 2001; 11: 969-977.
80. Boackle RJ, Connor MH, Vesely J. High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component. Mol Immunol 1993; 30: 309-319.
81. Mitoma M, Oho T, Shimazaki Y, Koga T. Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin. J Biol Chem 2001; 276: 18060-18065.
82. Oho T, Yu H, Yamashita Y, Koga T. Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans. Infect Immun 1998; 66: 115-121.
83. Thim L, Mortz E. Isolation and characterization of putative trefoil peptide receptors. Regul Pept 2000; 90: 61-68.
84. Sasaki M, Tsuneyama K, Saito T, Kataoka H, Mollenhauer J, Poustka A, et al. Site-characteristic expression and induction of trefoil factor family 1,2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology. Liver Int 2004; 24: 29-37.
85. Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, Lee A, et al. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci USA 2003; 100: 1292-1297.
86. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881-884.
87. Rawls JF, Samuel BS, Gordon JI. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci USA 2004; 101: 4596-4601.
88. Kang W, Nielsen O, Fenger C, Madsen J, Hansen S, Tornoe I, et al. The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester. Clin Exp Immunol 2002; 130: 449458.
89. Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Muller T. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and Orcadian clock gene expression. Toxicol Sci 2006; 93: 422431.
90. White MR, Crouch E, Vesona J, Tacken PJ, Batenburg JJ, Leth-Larsen R, et al. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol 2005; 289: L606-616.
91. Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol 2004; 114: 783-790.
92. De Lisle RC. Increased expression of sulfated gp300 and acinar tissue pathology in pancreas of CFTR-/- mice. Am J Physiol 1995; 268: 717-723.
93. De Lisle RC, Petitt M, Huff J, Isom KS, Agbas A. MUCLIN expression in the cystic fibrosis transmembrane conductance regulator knockout mouse. Gastroenterology 1997; 113: 521-532.
94. Afdhal NH, Niu N, Gantz D, Small DM, Smith BF. Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile. Gastroenterology 1993; 104: 1515-1523.
95. Nunes DP, Keates AC, Afdhal NH, Offner GD. Bovine gall-bladder mucin contains two distinct tandem repeating sequences: evidence for scavenger receptor cysteine-rich repeats. Biochem J 1995; 310: 41-48.
96. Nunes DP, Afdhal NH, Offner GD. A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time. Gastroenterology 1999; 116: 936-942.
97. Sasaki M, Huang SF, Chen MF, Jan YY, Yeh TS, Ishikawa A, et al. Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis. Dig Dis Sci 2003; 48: 1234-1240.
98. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6: 376-388.
99. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006; 79: 439-448.
100. Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res 2000; 1: 93-108.
101. Jovine L, Qi H, Williams Z, Litscher E, Wassarman PM. The ZP domain is a conserved module for polymerization of extracellular proteins. Nat Cell Biol 2002; 4: 457461.
102. Bikker FJ, Ligtenberg AJ, End C, Renner M, Blaich S, Lyer S, et al. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains. J Biol Chem 2004; 279: 47699-47703.
103. Wu Z, Lee S, Abrams W, Weissman D, Malamud D. The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection. AIDS Res Hum Retroviruses 2006; 22: 508-515.
104. Ligtenberg AJ, Bikker FJ, De Blieck-Hogervorst JM, Veerman EC, Nieuw Amerongen AV. Binding of salivary agglutinin to IgA. Biochem J 2004; 383: 159-164.
105. Oho T, Bikker FJ, Nieuw Amerongen AV, Groenink J. A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain. Infect Immun 2004; 72: 6181-6184.
106. Prakobphol A, Boren T, Ma W, Zhixiang P, Fisher SJ. Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori. Biochemistry 2005; 44: 2216-2224.
107. Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV. A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans. Antonie Van Leeuwenhoek 2000; 77: 21-30.
108. Jenkinson HF, Demuth DR. Structure, function and immunogenicity of streptococcal antigen I/II polypeptides. Mol Microbiol 1997; 23: 183-190.
109. Demuth DR, Davis CA, Corner AM, Lamont RJ, Leboy PS, Malamud D. Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin. Infect Immun 1988; 56: 2484-2490.
110. Brady LJ, Piacentini DA, Crowley PJ, Oyston PC, Bleiweis AS. Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1. Infect Immun 1992; 60: 1008-1017.
111. Crowley PJ, Brady LJ, Piacentini DA, Bleiweis AS. Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans. Infect Immun 1993; 61: 1547-1552.
112. Senpuku H, Miyauchi T, Hanada N, Nisizawa T. An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components. Infect Immun 1995; 63: 46954703.
113. Jakubovics NS, Stromberg N, van Dolleweerd CJ, Kelly CG, Jenkinson HF. Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial Ugands. Mol Microbiol 2005; 55: 1591-1605.
114. Loimaranta V, Jakubovics NS, Hytonen J, Finne J, Jenkinson HF, Stromberg N. Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties. Infect Immun 2005; 73: 2245-2252.
115. Jakubovics NS, Kerrigan SW, Nobbs AH, Stromberg N, van Dolleweerd CJ, Cox DM, et al. Functions of cell surface-anchored antigen I/II famliy and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors. Infect Immun 2005; 73: 6629-6638.
116. Takamatsu D, Bensing BA, Prakobphol A, Fisher SJ, Sullam PM. Binding of the streptococcal surface glycoproteins GspB and Hsa to human salivary proteins. Infect Immun 2006; 74: 1933-1940.
117. Oli MW, McArthur WP, Brady LJ. A whole cell BIAcore assay to evaluate Pl-mediated adherence of Streptococcus mutans to human salivary agglutinin and inhibition by specific antibodies. J Microbiol Methods 2006; 65: 503-511.
118. Hakkarainen J, Toivanen M, Leinonen A, Frangsmyr L, Stromberg N, Lapinjoki S, et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. J Nutr 2005; 135: 2445-2448.
119. Zhang Y, Lei Y, Nobbs A, Khammanivong A, Herzberg MC. Inacrivation of Streptococcus gordorui SspAB alters expression of multiple adhesin genes. Infect Immun 2005; 73: 3351-3357.
120. Hamada T, Kawashima M, Watanabe H, Tagami J, Senpuku H Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components. Infect Immun 2004; 72: 4819-4826.
121. Wu Z, Van Ryk D, Davis C, Abrams WR, Chaiken I, Magnani J, et al. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. AIDS Res Hum Retroviruses 2003; 19: 201-209.
122. Wu Z, Golub E, Abrams WR, Malamud D. gp340 (SAG) binds to the V3 sequence of gpl20 important for chemokine receptor interaction. AIDS Res Hum Retroviruses 2004; 20: 600-607.
123. Hartshorn KL, Ligtenberg A, White MR, Van Eijk M, Hartshorn M, Pemberton L, et al. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J 2006; 393: 545-553.
124. Eriksson C, Frangsmyr L, Danielsson Niemi L, Loimaranta V, Holmskov U, Bergman T, et al. Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation. Glycoconj J 2007; 24: 131-142.
125. Jonasson A, Eriksson C, Jenkinson HF, Kallestal C, Johansson I, Stromberg N. Innate immunity glycoprotein gp-340 variants may modulate human susceptibility to dental caries. BMC Infect Dis 2007; 7: 57.
126. End C, Lyer S, Renner M, Stahl C, Ditzer J, Holloschi A, et al. Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1. Protein Expr Purif 2005; 41: 275-286.
127. Hardwidge PR, Rodriguez-Escudero I, Goode D, Donohoe S, Eng J, Goodlett DR, et al. Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli. J Biol Chem 2004; 279: 20127-20136.
128. Grys TE, Siegel MB, Lathem WW, Welch RA. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect Immun 2005; 73: 1295-1303.
129. Stoddard E, Cannon G, Ni H, Kariko K, Capodici J, Malamud D, et al. gp340 expressed on human genital epithelia binds HIV-I envelope protein and facilitates viral transmission. J Immunol 2007; 179: 3126-3132.
130. Kellam P, Weiss RA. Infectogenomics: Insights from the host genome into infectious diseases. Cell 2006; 124: 695-697.
131. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461466.
132. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKK, couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977-990.
133. Muller WE. Review: How was metazoan threshold crossed? The hypothetical Urmetazoa. Comp Biochem Physiol A Mol Integr Physiol 2001; 129: 433460.
134. Muller WE, Koziol C, Muller IM, Wiens M. Towards an understanding of the molecular basis of immune responses in sponges: The marine demosponge Geodia cydonium as a model. Microsc Res Tech 1999; 44: 219-236.
135. Pancer Z, Munkner J, Muller I, Muller WE. A novel member of an ancient superfamily: Sponge (Geodia cydonium, Porifera) putative protein that features scavenger receptor cysteine-rich repeats. Gene 1997; 193: 211-218.
136. Blumbach B, Pancer Z, Diehl-Seifert B, Steffen R, Munkner J, Muller I, et al. The putative sponge aggregation receptor. Isolation and characterization of a molecule composed of scavenger receptor cysteine-rich domains and short consensus repeats. J Cell Sci 1998; 111: 2635-2644.
137. Pahler S, Blumbach B, Muller I, Muller WE. Putative multiadhesive protein from the marine sponge Geodia cydonium: Cloning of the cDNA encoding a fibronectin-, an SRCR-, and a complement control protein module. J Exp Zool 1998; 282: 332-343.
138. Vila JM, Padilla O, Annan M, Gimferrer I, Lozano F. The scavenger receptor cysteine-rich superfamily (SRCR-SF). Structure and Function of group B members. Inmunologia 2000; 19: 105-121.
139. Steindler L, Schuster S, Ilan M, Avni A, Cerrano C, Beer S. Differential gene expression in a marine sponge in relation to its symbiotic state. Mar Biotechnol (NY) 2007; 9: 543-549.
140. Pancer Z. Dynamic expression of multiple scavenger receptor cysteine-rich genes in coelomocytes of the purple sea urchin. Proc Natl Acad Sci USA 2000; 97: 13156-13161.
141. Kang W, Reid KB. DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration? FEBS Lett 2003; 540: 21-25.